 Fentanyl         

[![back](images/backarrow.png)](Content_Hub_Individual_Opioids.html)

Fentanyl
========

[![home](images/homebtn.png)](main_menu.html)

Opioid analgesic of short duration for management of moderate to severe pain

Formulations:

*   Transdermal patch (12, 25, 50, 75 and 100mcg/hour)
*   Transmucosal (Actiq, 200, 400 ,600, 800mcg lozenge)
*   Injection (50 mcg/ml, no PBS subsidy)

Benefits:

*   Non parenteral formulations for patients unable to take oral meds
*   Inactive metabolites
*   Possibly less constipating (compared with morphine)
*   Short half-life
*   Safe in renal failure

Limitations:

*   No oral preparation
*   Patch adhesion not always ideal
*   Dose of patch limited by physical constraints
*   Slow dose titration
*   Short half life

Dose conversion:

*   12.5mcg/hour patch = approx. 30-45mg oral morphine/day
*   25mcg/hour patch= approx. 90mg oral morphine/day
*   no correlation between fentanyl lozenge size and morphine dose
*   start with low dose and titrate

![cpcre](images/banner-long-footer-whitetext.png) ![cpcre](images/acrrm.png)